Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

VZIG clinical studies progress in post-herpetic neuralgia

Sep. 6, 1996

Russian launch for GMDP

Sep. 6, 1996

Abbott describes immunosuppressants

Sep. 6, 1996

Interferon production enhancer discovered by Japanese researchers

Sep. 6, 1996

New agents for use in transplantation

Aug. 30, 1996

Aviron's intranasal influenza vaccine begins phase III

Aug. 30, 1996

FDA approval requested for thymoglobin manufacturing process, facility

Aug. 30, 1996

STV: Possible antituberculosis and autoimmune disease therapy

Aug. 23, 1996

Immunomodulating peptides from BioChem Pharma

Aug. 23, 1996

Cel-Sci and U.S. Navy collaborate on malaria vaccine

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...